ALKS 外匯新聞
Alkermes Reiterates FY24 Revenue Outlook - Update
While reporting financial results for the second quarter on Wednesday, biopharmaceutical company Alkermes plc (ALKS) reiterated its revenue guidance for the full-year 2024.
RTTNews
|
172天前
